Table of Contents
From the Editor
- Double the reasons for giving the flu vaccine in 2020Limiting the impact of other diseases, possibly including COVID-19. 
The Clinical Picture
1-Minute consult
- Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?The short answer is no—but it is not that simple. 
COVID-19 Curbside Consults
- Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19Consider the presentation and trajectory of illness. 
- Convalescent plasma for COVID-19: Promising, not provenThe evidence is suggestive but weak. Trials are ongoing. 
Review
- Using and interpreting electrodiagnostic testsThey supplement a neurologic examination in a variety of neuromuscular conditions. 
- Contrast media in patients with kidney disease: An updateThe risk of acute kidney injury is real, but lower than initially thought. 
- The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adultsPatients can have variable responses to vaccines, depending on the vaccine and the DMARD. 





Commentary
Measures to combat COVID-19 can minimize the impact of flu, and vice versa.